Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
73.78
-0.56 (-0.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
33
34
Next >
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
FTX Contagion Spreads To Hong Kong Exchange, Microsoft Outlines New Harassment Policies, Netflix Subscribers Can Terminate Freeloading Account Access: Top Stories Wednesday, Nov. 16
November 16, 2022
Benzinga
Via
Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
Via
Benzinga
Has This Hot Stock Run Out of Steam?
November 10, 2022
Shares of Gilead Sciences have been have been on a tear recently.
Via
The Motley Fool
Why Shares of Gilead Sciences Rose 27.20% in October
November 08, 2022
The company's growing oncology portfolio is driving increased revenues.
Via
The Motley Fool
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
Learn More about Organicell Regenerative Medicine, Inc. by gaining access to the latest research report In the medical community, the popularity of regenerative medicine is reportedly soaring primarily...
Via
Benzinga
2 Top Biotech Stocks to Buy in November
November 12, 2022
Both of these companies have potential catalysts on the way.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
November 08, 2022
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 8.27% on an annualized basis producing an average annual return of 15.72%. Currently, Gilead Sciences has a market...
Via
Benzinga
Gilead Sciences Unusual Options Activity
November 08, 2022
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead
November 07, 2022
Via
Benzinga
Gilead Sciences (GILD) Q3 2022 Earnings Call Transcript
October 27, 2022
GILD earnings call for the period ending September 30, 2022.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in November
November 05, 2022
There's no need for agonizing decision-making with these great dividend stocks.
Via
The Motley Fool
G1 Therapeutics Says Its Lead Candidate May Cut Adverse Events Of Gilead's Breast Cancer Drug
November 02, 2022
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
November 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Biogen To Rally Around 15%? Here Are 5 Other Price Target Changes For Tuesday
November 01, 2022
Mizuho raised Biogen Inc. (NASDAQ: BIIB) price target from $270 to $325. Mizuho analyst Salim Syed maintained the stock with a Buy rating. Biogen shares fell 0.3% to close at $283.44 on Monday.
Via
Benzinga
Can Biotech Stocks Continue Rallying In This Bear Market?
October 31, 2022
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
A Look Into Gilead Sciences's Debt
October 31, 2022
Over the past three months, shares of Gilead Sciences Inc. (NASDAQ:GILD) rose by 26.52%. Before we understand the importance of debt, let's look at how much debt Gilead Sciences has.
Via
Benzinga
Healthcare & Biotech Stocks: A Big Opportunity In 2023
October 30, 2022
One of the areas that will come with opportunities for stock market investors in 2023 is the health care sector. This includes pharma, medical devices, biotech, and the likes.
Via
Talk Markets
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
These 2 Stock Winners Topped Apple's Big Gains Friday
October 28, 2022
Strong earnings helped lift the market.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Check Out What Whales Are Doing With GILD
October 28, 2022
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list...
Via
Benzinga
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday
October 28, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Upgrades
Via
Benzinga
Analysts Turn Bullish On Gilead After Q3 Earnings Surpass Expectations
October 28, 2022
Via
Benzinga
Where Gilead Sciences Stands With Analysts
October 28, 2022
Over the past 3 months, 8 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
October 28, 2022
Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday.
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.